Gut Microbiota, Pharmacogenetics and Integrase Strand Transfer Inhibitors Response
Latest Information Update: 15 May 2024
At a glance
- Drugs Bictegravir (Primary) ; Dolutegravir (Primary)
- Indications HIV infections
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 15 May 2024 Last checked against ClinicalTrials.gov: US National Institutes of Health
- 08 May 2024 Status changed from recruiting to completed.
- 24 Mar 2021 New trial record